Medicare Enrolled
Dr. Mark Kramar, M.D.
Ophthalmology · Encino, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kramar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kramar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kramar
Dr. Mark Kramar is an ophthalmology specialist in Encino, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kramar performed 7,972 Medicare services across 6,250 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kramar received a total of $3,310 from 26 pharmaceutical and/or device companies across 101 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kramar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 12% volume in CA
$3,310 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,972
Medicare services
Top 12% in CA for ophthalmology
6,250
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~420 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
1,951 | $74 | $120 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,775 | $99 | $180 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
1,143 | $30 | $130 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
676 | $28 | $130 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
636 | $53 | $125 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
340 | $34 | $130 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
326 | $22 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
209 | $136 | $215 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
178 | $450 | $3,000 |
| Microfluid analysis of tears A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes. |
111 | $22 | $50 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
95 | $24 | $65 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
92 | $9 | $30 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
80 | $293 | $1,100 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
80 | $91 | $210 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
70 | $210 | $1,800 |
| Tear duct plug insertion A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface. |
68 | $194 | $399 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
23 | $736 | $2,200 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
20 | $622 | $3,200 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $94 | $165 |
| Removal of chronic eyelid growth This procedure involves the surgical removal of a long-standing growth on the eyelid. |
18 | $105 | $320 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
17 | $25 | $75 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
17 | $16 | $125 |
| Contact lens fitting for eye surface disease This procedure involves the fitting of a contact lens specifically intended to treat or manage a disease affecting the surface of the eye. |
17 | $32 | $75 |
| Eye photography Photographic imaging of the interior structures of the eye. |
11 | $20 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.2% high complexity
14.1% medium
83.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,310
Total received (2018-2024)
Avg $473/year across 7 years
Top 33% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
101
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,310 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$749
2023
$391
2022
$837
2021
$161
2020
$189
2019
$532
2018
$452
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$376
SUN PHARMACEUTICAL INDUSTRIES INC.
$89
Dompe US, Inc.
$67
Tarsus Pharmaceuticals, Inc.
$66
ABBVIE INC.
$46
Bausch & Lomb Americas Inc.
$39
Harrow Eye, LLC
$34
Thea Pharma Inc.
$32
Top 3 companies account for 71.0% of 2024 payments
All-time payments by company (2018-2024) ›
Glaukos Corporation
$760
Bausch & Lomb, a division of Bausch Health US, LLC
$351
Sun Pharmaceutical Industries Inc.
$254
Aerie Pharmaceuticals, Inc.
$231
Optos, Inc.
$226
GLAUKOS CORPORATION
$150
Novartis Pharmaceuticals Corporation
$145
SUN PHARMACEUTICAL INDUSTRIES INC.
$127
Alcon Vision LLC
$125
Shire North American Group Inc
$112
Dompe US, Inc.
$97
ABBVIE INC.
$93
Sight Sciences, Inc.
$93
Allergan, Inc.
$85
Bausch & Lomb Americas Inc.
$85
Tarsus Pharmaceuticals, Inc.
$66
Thea Pharma Inc.
$52
Johnson & Johnson Surgical Vision, Inc.
$50
EYEVANCE PHARMACEUTICALS LLC
$48
Harrow Eye, LLC
$34
Alcon Laboratories Inc
$33
Oyster Point Pharma, Inc.
$25
Akorn, Inc.
$23
BioTissue Holdings, Inc.
$16
RxSight Inc
$15
Akorn Operating Company LLC
$15
Top 3 companies account for 41.3% of all-time payments
Associated products mentioned in payments ›
AcrySof IQ VIVITY · BROMSITE · CEQUA · Cequa · DAILIES · DUREZOL · DURYSTA · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MIEBO · NGENUITY · OCT OPHTHALMOSCOPE · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · PROKERA · RXSIGHT CONTACT LENS · ReSTOR · Rhopressa · Rocklatan · TYRVAYA · Tecnis IOL · Tecnis Simplicity · TobraDex ST · VEVYE · VUITY · VYZULTA · XDEMVY · XIIDRA · Zioptan · iDose · iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM · iStent Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Ophthalmologists within 10 mi
656
Per 100K population
6.7
County median income
$87,760
Nearest hospital
ENCINO HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kramar is a mixed practice specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kramar experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Kramar performed 1,951 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kramar receive payments from pharmaceutical companies?
Yes. Dr. Kramar received a total of $3,310 from 26 companies across 101 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kramar's costs compare to other ophthalmologists in Encino?
Dr. Kramar's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kramar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Encino
Browse ophthalmologists in Encino ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in CA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in CA
Which CA ophthalmologists receive the most from drug and device companies.
By company
Glaukos Corporation Payments to Doctors
See all physicians who received payments from Glaukos Corporation.
By company
Bausch & Lomb, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Bausch & Lomb, a division of Bausch Health US, LLC.
By company
Sun Pharmaceutical Industries Inc. Payments to Doctors
See all physicians who received payments from Sun Pharmaceutical Industries Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology